Preclinical testing of N-[11c]-methyl-piperidin-4-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate, a novel radioligand for detection of cerebral muscarinic receptors using PET
- 30 November 1999
- Vol. 35 (1) , 62-67
- https://doi.org/10.1002/(sici)1098-2396(200001)35:1<62::aid-syn8>3.0.co;2-1
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rateBritish Journal of Clinical Pharmacology, 1997
- Selective Muscarinic Receptor Agonists and AntagonistsBasic & Clinical Pharmacology & Toxicology, 1996
- Autoradiographic Evidence That 3-Quinuclidinyl-4-fluorobenzilate (FQNB) Displaysin VivoSelectivity for the m2 SubtypeNeuroImage, 1996
- Characterization of in vivo brain muscarinic acetylcholine receptor subtype selectivity by competition studies against (
I]QNB Brain Research, 1995 - In vivo Muscarinic Cholingeric Receptor Imaging in Human Brain with [11C]Scopolamine and Positron Emission TomographyJournal of Cerebral Blood Flow & Metabolism, 1992
- Mapping muscarinic receptors in human and baboon brain using [N‐11C‐methyl]‐benztropineSynapse, 1990
- Muscarinic Receptor SubtypesNew England Journal of Medicine, 1989
- Synthesis of radiotracers for studying muscarinic cholinergic receptors in the living human brain using positron emission tomography: [11C]dexetimide and [11C]levetimideInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1988
- In vivo studies of opiate receptorsAnnals of Neurology, 1984
- The central and peripheral activities of anti-acetylcholine drugs. Some concepts of practical relevanceJournal of Pharmacy and Pharmacology, 1973